Determining the full amount of atrial fibrillation (AF) a patient is enduring may be the key to personalized AF management. How could using this measure in addition to standard stroke risk profiles enhance clinical decision making for patients with paroxysmal atrial fibrillation (PAF)?
Dr. Michael Mirro, Chief Academic and Research Officer of Parkview Health shares his perspective on managing PAF patients and how the results from the KP-RHYTHM study could impact clinical practice. View the full conversation below.
Dr. Mirro gives his take on the AHA Scientific Statement discussing the concept of AF burden.
Dr. Mirro explains why 24-to-48-hour monitoring is inadequate to accurately measure true AF burden.
Dr. Mirro talks about how AF burden can help clinicans reinforce medication adherence in patients by precisely clarifying their stroke risk.